Systematic review of mesotherapy: a novel avenue for the treatment of hair loss.


Journal

The Journal of dermatological treatment
ISSN: 1471-1753
Titre abrégé: J Dermatolog Treat
Pays: England
ID NLM: 8918133

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive substances are administered by intradermal injections to the skin. Through intradermal injections, mesotherapy can increase the residence time of therapeutic agents in the affected area, thus allowing for the use of lower doses and longer intervals between sessions which may in turn improve the treatment outcome and patient compliance. This systematic review aims to summarize the current literature that evaluates the efficacy of this technique for the treatment of hair loss and provides an overview of the results observed. Of the 416 records identified, 27 articles met the inclusion criteria. To date, mesotherapy using 6 classes of agents and their combinations have been studied; this includes dutasteride, minoxidil, growth factors or autologous suspension, botulinum toxin A, stem cells, and mesh solutions/multivitamins. While several studies report statistically significant improvements in hair growth after treatment, there is currently a lack of standardized regimens. The emergence of adverse effects after mesotherapy has been reported. Further large-scale and controlled clinical trials are warranted to evaluate the utility of mesotherapy for hair loss disorders.

Identifiants

pubmed: 37558233
doi: 10.1080/09546634.2023.2245084
doi:

Substances chimiques

Minoxidil 5965120SH1

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2245084

Auteurs

Aditya K Gupta (AK)

Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada.
Mediprobe Research Inc, London, Canada.

Shruthi Polla Ravi (S)

Mediprobe Research Inc, London, Canada.

Tong Wang (T)

Mediprobe Research Inc, London, Canada.

Mesbah Talukder (M)

Mediprobe Research Inc, London, Canada.
School of Pharmacy, BRAC University, Dhaka, Bangladesh.

Michela Starace (M)

Dermatology Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Italy.

Bianca Maria Piraccini (BM)

Dermatology Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH